Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacovigilance01:19

Pharmacovigilance

783
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
783
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

412
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
412
Drug Control Governance: Regulatory Bodies and Their Impact01:03

Drug Control Governance: Regulatory Bodies and Their Impact

144
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
144
Preclinical Development: Overview01:28

Preclinical Development: Overview

4.3K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.3K
Biopharmaceutics and Pharmacokinetics: Overview01:28

Biopharmaceutics and Pharmacokinetics: Overview

1.9K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
1.9K
Drug Regulation01:25

Drug Regulation

1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Comparative Analysis of the Regulatory Framework and Collaborative Environment for Pediatric Medical Device Development in Japan and the United States: Identifying Challenges, Support Mechanisms, and Emerging Opportunities.

Cureus·2024
Same author

Phytosome Technology: A Novel Breakthrough for the Health Challenges.

Cureus·2024
Same author

The Biosimilar Revolution: Assessing the European Union's Approach to Biosimilarity, Interchangeability, Patient Access, and Its Market Analysis.

Cureus·2024
Same author

A Review of the Regulatory Challenges of Personalized Medicine.

Cureus·2024
Same author

A Comprehensive Analysis of Class I Medical Device Recalls: Unveiling Patterns, Causes and Global Impacts.

Cureus·2024
Same author

Increasing Risk Factors for Non-Alcoholic Fatty Liver Disease; an Insight into Chronic Periodontitis and Insulin Resistance.

Endocrine, metabolic & immune disorders drug targets·2022

Related Experiment Video

Updated: Jun 10, 2025

Visualizing and Quantifying Pharmaceutical Compounds within Skin using Coherent Raman Scattering Imaging
11:07

Visualizing and Quantifying Pharmaceutical Compounds within Skin using Coherent Raman Scattering Imaging

Published on: November 24, 2021

2.7K

Pharmaceutical Inspection Co-operation Scheme: An Overview.

Prasanna Gayathri B1, Kamaraj R1

  • 1Pharmacy, SRM Institute of Science and Technology, Chennai, IND.

Cureus
|October 11, 2024
PubMed
Summary

The Pharmaceutical Inspection Co-operation Scheme (PIC/S) harmonizes global regulatory requirements for Good Manufacturing Practice (GMP) compliance. This collaboration enhances inspection efficiency and builds trust among 56 participating countries.

Keywords:
accessiongmp compliancegmp requirementsinformation exchangeinspectoratesinternational cooperationnetworkingpharmaceutical inspection co-operation scheme (pic/s)pic/s gmp forumpre-accession.

More Related Videos

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
09:30

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

3.3K
Fast Inspection of Quality of Indigo Naturalis by Multiple Light Scattering
03:40

Fast Inspection of Quality of Indigo Naturalis by Multiple Light Scattering

Published on: August 18, 2023

374

Related Experiment Videos

Last Updated: Jun 10, 2025

Visualizing and Quantifying Pharmaceutical Compounds within Skin using Coherent Raman Scattering Imaging
11:07

Visualizing and Quantifying Pharmaceutical Compounds within Skin using Coherent Raman Scattering Imaging

Published on: November 24, 2021

2.7K
Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
09:30

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

3.3K
Fast Inspection of Quality of Indigo Naturalis by Multiple Light Scattering
03:40

Fast Inspection of Quality of Indigo Naturalis by Multiple Light Scattering

Published on: August 18, 2023

374

Area of Science:

  • Pharmaceutical Regulation
  • International Cooperation
  • Good Manufacturing Practice (GMP)

Background:

  • Globalization presents challenges for regulatory agencies, necessitating harmonization of requirements.
  • Effective management of GMP compliance, facility licensing, and product recalls is crucial.
  • Improved information exchange among international regulatory bodies is essential.

Purpose of the Study:

  • To establish uniform GMP standards globally.
  • To provide comprehensive training for inspectors.
  • To foster collaboration among international regulatory organizations.

Main Methods:

  • Utilizing the Pharmaceutical Inspection Co-operation Scheme (PIC/S) framework.
  • Facilitating informal interactions through the PIC/S GMP Forum.
  • Developing and disseminating a comprehensive guide on GMP requirements.
  • Promoting the exchange of inspection reports among authorities.

Main Results:

  • Enhanced networking and collaboration among regulatory authorities.
  • Consistent application of GMP standards across borders.
  • Verification of compliance with PIC/S standards through inspection report exchange.
  • Reduction in the number and increase in the specificity of inspections.

Conclusions:

  • PIC/S plays a pivotal role in advancing global pharmaceutical regulatory practices.
  • The scheme optimizes resource utilization and fosters a more efficient regulatory environment.
  • Building trust in inspections is a key outcome of PIC/S initiatives.